Evidence map›Paper›PMID 37452793›Full record

ArticleEpilepsia2023

High-dose folic acid and cancer risk; unjustified concerns by von Wrede and colleagues regarding our paper.

Marte-Helene Bjørk, Torbjörn Tomson, Julie Werenberg Dreier, Silje Alvestad, Nils Erik Gilhus, Mika Gissler, Jannicke Igland, Maarit K Leinonen, Yuelian Sun, Håkon Magne Vegrim and 2 more

Abstract readComment
PubMed Publisher
In one paragraph

Article in Epilepsia, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Marte-Helene BjørkDepartment of Clinical Medicine, University of Bergen, Bergen, Norway.ORCID 0000-0002-5745-1094
Torbjörn TomsonDepartment of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden.ORCID 0000-0003-0554-5352
Julie Werenberg DreierNational Centre for Register-Based Research, School of Business and Social Sciences, Aarhus University, Aarhus, Denmark.ORCID 0000-0002-9339-4170
Silje AlvestadDepartment of Clinical Medicine, University of Bergen, Bergen, Norway.ORCID 0000-0003-4655-8109
Nils Erik GilhusDepartment of Clinical Medicine, University of Bergen, Bergen, Norway.ORCID 0000-0001-6522-5102
Mika GisslerKnowledge Brokers, Finnish Institute for Health and Welfare, Helsinki, Finland.ORCID 0000-0001-8254-7525
Jannicke IglandDepartment of Global Public Health and Primary Care, University of Bergen, Bergen, Norway.ORCID 0000-0002-2289-0978
Maarit K LeinonenKnowledge Brokers, Finnish Institute for Health and Welfare, Helsinki, Finland.ORCID 0000-0002-7631-4749
Yuelian SunDepartment of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark.ORCID 0000-0002-6905-0503
Håkon Magne VegrimDepartment of Clinical Medicine, University of Bergen, Bergen, Norway.ORCID 0000-0001-6432-2883
Helga ZoegaSchool of Population Health, Faculty of Medicine & Health, University of New South Wales, Sydney, Australia.ORCID 0000-0003-0761-9028
Jakob ChristensenDepartment of Neurology, Aarhus University Hospital, Aarhus, Denmark.ORCID 0000-0002-9385-6435

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Women using antiseizure medication in pregnancy are often advised to use high doses of folic acid supplements (1mg to 5 mg) to reduce the risk of teratogenicity. Recently, we published a report showing an association between maternal prescription fill of high dose folic acid in relation to pregnancy and childhood cancer in the offspring. The report has sparked a debate about which dose of folic acid that should be recommended in pregnancy in women in need of antiseizure medication. In this Commentary, we explain our findings and the method used in our report, and answer recent questions that have emerged.

Indexed as

Folic AcidNeoplasmsChildDietary SupplementsFamilyFemaleHumansPregnancyRiskFolic Acidanticonvulsant drugsantiepileptic drugB vitaminschildhood cancerepilepsyfolatepregnancy

Identifiers

PMID37452793

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.